REFERENCES
- Arnold J., Holmes Z., Pickering W., et al. Anti-beta 2 glycoprotein 1 and anti-annexin V antibodies in women with recurrent miscarriage. Br. J. Haematol 2001; 113: 911–914
- Berard M., Chantome R., Marcelli A., et al. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous diseases. J. Rheumatol. 1996; 23: 1369–1374
- Bertolaccini M. L., Atsumi T., Caliz A. R., et al. Association of antiphosphatidylserine/prothrombin autoantibodies with HLA class II genes. Arthritis Rheum 2000; 43: 683–688
- Bertolaccini M. L., Atsumi T., Koike T., et al. Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus. Thromb. Haemost. 2005; 93: 289–297
- Bizzaro N., Tonutti E., Villalta D., et al. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages. Arch. Pathol. Lab. Med. 2005; 129: 61–68
- Cabiedes J., Cabral A. R., Alarcon-Segovia D. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta2-glycoprotein-I than with antiphospholipid antibodies. J. Rheumatol. 1995; 22: 1899–1906
- Fleck R. A., Rapaport S. I., Rao L. V. M. Antiprothrombin antibodies and the lupus anticoagulant. Blood 1988; 72: 512–519
- Galeazzi M., Sebastiani G. D., Tincani A., et al. HLA class II associations of anticardiolipin and anti-β2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Lupus 2000; 9: 47–55
- Harris E. N., Gharavi A. E., Boey M. L., et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211–1214
- Hochberg. Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arth. Rheum 1997; 40: 1725
- Horkko S., Miller E., Dudi E., et al. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. J. Clin. Invest. 1996; 98: 815–825
- Kimura A., Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA-DNA typing technique. HLA 1991, K. Tsuji, M. Aizawa, T. Sasazuki. Oxford University Press, Oxford 1992; 397–419
- Lakos G., Kiss E., Regeczy N., et al. Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases. J. Rheumatol. 2000; 27: 924–929
- Levine J. S., Branch D. W., Rauch J. The antiphospholipid syndrome. N. Engl. J. Med. 2002; 346: 752–763
- Matsubayashi H., Arai T., Izumi S., et al. Anti-annexin V antibodies in patients with early pregnancy loss or implantation failures. Fertil. Steril. 2001; 76: 694–699
- Matsuda J., Saitoh N., Gohchi K., et al. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody. Am. J. Hematol 1994; 47: 56–58
- Roubey R. A. S. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum. 1996; 39: 1444–1454
- Sahin M., Duzgun N., Tunc S. E., et al. Clinical manifestations and antiphosphatidylserine antibodies in patients with systemic lupus erythematosus: is there an association?. Clin. Rheumatol 2007; 26: 154–160
- Sebastiani G. D., Minisola G., Galeazzi M. HLA class II alleles and genetic predisposition to the antiphospholipid syndrome. Autoimmun. Rev. 2003; 2: 387–394
- Sebastiani G. D., Galeazzi M., Morozzi G. Immunogenetics of the antiphospholipid syndrome. The Antiphospholipid Syndrome II – Autoimmune Thrombosis, R. A. Asherson, et al. Elsevier, Oxford 2002; 119–129
- Sebastiani G. D., Galeazzi M., Tincani A., et al. HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Lupus 2003; 12: 560–563
- Tarr T., Lakos G., Bhattoa H. P., Soltesz P., Shoenfeld Y., Szegedi G., Kiss E. Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up. Clin. Rev. Allergy Immunol 2007; 32: 131–137
- Viard J., Amoura Z., Bach J. Association of anti-beta2-glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am. J. Med. 1992; 93: 181–186